 | Monter d'un niveau |
Labbé, P., Munoz Goyette, V., Thorin-Trescases, N., Villeneuve, L., Desanlis, I., Delwarde, C., Shi, Y.-F., Martel, C., Yu, C., Alikashani, A., Mamarbachi, M., Lesage, F., Mathieu, S., Tardif, J.-C., Mathieu, P., Kmita, M., & Thorin, É. (2022). Angiopoietin-like 2 is essential to aortic valve development in mice. Communications Biology, 5(1), 18 pages. Lien externe
Pinçon, A., De Montgolfier, O., Akkoyunlu, N., Daneault, C., Pouliot, P., Villeneuve, L., Lesage, F., Levy, B. I., Thorin-Trescases, N., Thorin, É., & Ruiz, M. (2019). Non-alcoholic fatty liver disease, and the underlying altered fatty acid metabolism, reveals brain hypoperfusion and contributes to the cognitive decline in APP/PS1 mice. Metabolites, 9(5), 20 pages. Disponible
de Montgolfier, O., Pinçon, A., Pouliot, P., Gillis, M.-A., Bishop, J., Sled, J. G., Villeneuve, L., Ferland, G., Levy, B. I., Lesage, F., Thorin-Trescases, N., & Thorin, E. (2019). High systolic blood pressure induces cerebral microvascular endothelial dysfunction, neurovascular unit damage, and cognitive decline in mice. Hypertension, 73(1), 217-228. Lien externe
Maafi, F., Li, B., Gebhard, C., Brodeur, M. R., Nachar, W., Villeneuve, L., Lesage, F., Rhainds, D., Rhéaume, E., & Tardif, J.-C. (2017). Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo. Atherosclerosis, 258, 8-19. Lien externe
Drouin, A., Bolduc, V., Thorin-Trescases, N., Bélanger, É., Fernandes, P., Baraghis, E., Lesage, F., Gillis, M.-A., Villeneuve, L., Hamel, E., Ferland, G., & Thorin, E. (2011). Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice. American Journal of Physiology : Heart and Circulatory Physiology, 300(3), H1032-H1043. Lien externe
